With advantages in rate, accuracy and price per sample over phenotypic regular tests, the MALDI Biotyper has the potential to become a new clinical regular for microbial identification. Specifically, for fastidious microorganisms like anaerobic and non-fermenting bacterias the excellent discrimination power of the MALDI Biotyper offers shown in several publications. To be able to substantiate the MALDI Biotyper advantage specifically for difficult species in the daily scientific routine AGES would be the leading corporation for quality assurance and standardization for the evaluation after Legionella infections.Food and Medication Administration offers granted Orphan Medication Designation to volanesorsen for the treatment of patients with Familial Chylomicronemia Syndrome . FCS is a rare genetic disease seen as a high triglyceride levels and threat of pancreatitis extremely. In a Phase 2 study published in the NEJM in December 2014, individuals with FCS treated with volanesorsen accomplished substantial reductions in apoC-III, triglycerides, chylomicrons and apoC-III-associated very low density lipoprotein-cholesterol particles.